The N-end rule pathway of protein degradation. [Genes Cells. 1997] - PubMed

loading

Review The N-end rule: functions, mysteries, uses. [Proc Natl Acad Sci U S A. 1996]
Review The N-end rule: functions, mysteries, uses.
Varshavsky A. Proc Natl Acad Sci U S A. 1996 Oct 29; 93(22):12142-9.
The N-end rule is mediated by the UBC2(RAD6) ubiquitin-conjugating enzyme. [Proc Natl Acad Sci U S A. 1991]
The N-end rule is mediated by the UBC2(RAD6) ubiquitin-conjugating enzyme.
Dohmen RJ, Madura K, Bartel B, Varshavsky A. Proc Natl Acad Sci U S A. 1991 Aug 15; 88(16):7351-5.
Degradation of G alpha by the N-end rule pathway. [Science. 1994]
Degradation of G alpha by the N-end rule pathway.
Madura K, Varshavsky A. Science. 1994 Sep 2; 265(5177):1454-8.
Degradation of a cohesin subunit by the N-end rule pathway is essential for chromosome stability. [Nature. 2001]
Degradation of a cohesin subunit by the N-end rule pathway is essential for chromosome stability.
Rao H, Uhlmann F, Nasmyth K, Varshavsky A. Nature. 2001 Apr 19; 410(6831):955-9.
Review The ubiquitin-mediated proteolytic pathway: mechanisms of action and cellular physiology. [Biol Chem Hoppe Seyler. 1994]
Review The ubiquitin-mediated proteolytic pathway: mechanisms of action and cellular physiology.
Ciechanover A. Biol Chem Hoppe Seyler. 1994 Sep; 375(9):565-81.

Fission yeast 26S proteasome mutants are multi-drug resistant due to stabilization of the Pap1 transcription factor. [PLoS One. 2012]
Fission yeast 26S proteasome mutants are multi-drug resistant due to stabilization of the Pap1 transcription factor.
Penney M, Samejima I, Wilkinson CR, McInerny CJ, Mathiassen SG, Wallace M, Toda T, Hartmann-Petersen R, Gordon C. PLoS One. 2012; 7(11):e50796. Epub 2012 Nov 27.
From Bortezomib to other Inhibitors of the Proteasome and Beyond. [Curr Pharm Des. 2013]
From Bortezomib to other Inhibitors of the Proteasome and Beyond.
Buac D, Shen M, Schmitt S, Kona FR, Deshmukh R, Zhang Z, Neslund-Dudas C, Mitra B, Dou QP. Curr Pharm Des. 2013; 19(22):4025-38.
Drug Target Exploitable Structural Features of Adenylyl Cyclase Activity in Schistosoma mansoni. [Drug Target Insights. 2012]
Drug Target Exploitable Structural Features of Adenylyl Cyclase Activity in Schistosoma mansoni.
Mbah AN, Kamga HL, Awofolu OR, Isokpehi RD. Drug Target Insights. 2012; 6:41-58. Epub 2012 Oct 24.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
OMIM (calculated)
Online Mendelian Inheritance in Man (OMIM) records that include the current articles as references in the light bulb links within or in the citations at the end of the OMIM record. The references available through the light bulb link are collected using the PubMed related articles algorithm to identify records with similar terminology to the OMIM record.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

The N-end rule pathway of protein degradation.
The N-end rule pathway of protein degradation.
Genes Cells. 1997 Jan ;2(1):13-28.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed